Read the ‘2025 MSK Annual Report’
The ‘2025 MSK Annual Report: Progress Made Personal’ highlights research breakthroughs from the past year and features inspiring stories from across the MSK community. Discover how your generosity is helping MSK achieve our mission of ending cancer for life.
Highlights
The 2025 MSK Annual Report highlights $546 million raised through 484,000 donations — powering cancer research, patient care, and education at MSK.
Stories featured in the Annual Report show how philanthropy drives cancer breakthroughs by expanding clinical trials, advancing immunotherapy, training future scientists and physicians, and more.
The full report also recognizes MSK donors and benefactors and illustrates how every person in the MSK Giving community helps reinforce MSK’s mission to end cancer for life.
The ‘2025 MSK Annual Report: Progress Made Personal’
In 2025, more than 348,000 individuals, families, foundations, and companies contributed 484,000 donations — raising $546 million for cancer care, research, and education at Memorial Sloan Kettering Cancer Center (MSK).
Thanks to this support, MSK is able to build on a remarkable legacy of discovery, innovation, and compassionate care. From trailblazing translational research to new FDA-approved treatments, MSK physicians, scientists, and care teams are making meaningful strides against cancer every day — bringing new hope to patients and families around the world.
The 2025 MSK Annual Report: Progress Made Personal highlights these achievements and reflects a year defined by progress, momentum, and possibility. The stories within, including the ones featured below, show how philanthropy plays a critical role in advancing MSK’s mission of ending cancer for life:
Replacing fear with possibility: Learn how expanding access to clinical trials is allowing more patients to receive MSK’s lifesaving care without leaving their homes — even across state lines. Read how MSK is bringing care closer to home.
Tackling immunotherapy’s big challenges: See why MSK researchers are learning everything they can about how a person’s own immune system may be used to fight cancer. Learn how MSK researchers are pushing immunotherapy forward.
Training the next generation: Get to know some of the distinguished alumni of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences and their powerful experiences with mentorship. See mentorship in action.
MSK’s excellence is fueled by the extraordinary generosity of our donor community — which enables us to pursue bold ideas, accelerate promising research, and deliver exceptional care when it matters most.
Thank you to MSK’s Benefactors and Honor Roll donors
MSK is proud to recognize the extraordinary philanthropy of our Benefactors — individuals whose lifetime giving surpasses $1 million — as well as Honor Roll donors, who have contributed more than $100,000 in 2025.